TympaHealth

What TympaHealth does

TympaHealth is a London-headquartered health technology company founded by ENT surgeon Dr. Krishan Ramdoo that has built an integrated ear and hearing health platform anchored by the Tympa device — a portable, CE-marked Class 1 medical device (also FDA registered) that combines HD video otoscopy with 9.2x magnification, a 4-frequency hearing check (500Hz to 4kHz), and microsuction wax removal in a single unit. The hardware is paired with TympaCloud for digital patient records, a Remote Review service that enables frontline practitioners to escalate cases to ENT-trained audiologists and ENT surgeon partners, and Tympa Academy, an accredited training and certification program covering otoscopy, hearing checks, and aural care using microsuction.

The company operates a B2B2C model that sells subscription-based access to the device and platform bundled with training, accreditation, and ongoing support, while generating recurring consumables revenue from specula, suction tubes, and filters. Customer segments span UK community pharmacies (both independents and chains such as Peak Pharmacy with 46+ branches), residential and nursing care homes (Care UK, TLC Care, White House Nursing Home), audiology clinics (Hidden Hearing, Boots Hearingcare, The Hearing Care Partnership), allied health professionals, and — more recently — US primary care clinics and value-based hospital systems anchored by the Sanitas Reina pilot in Florida. Distribution is enabled by partnerships with the National Pharmacy Association, Care England, Numark Pharmacy, and Pharmacy Mentor, plus direct field sales in the UK and US.

The platform is differentiated by an unusually dense compliance stack (DTAC, HIPAA, NHS DSPT, GDPR, Cyber Essentials, CCPA) and by NHS-validated economic evidence — most notably a £262,079 net saving across a 20-pharmacy NHS South West London ICB pilot at £49.01 per patient with 99% patient satisfaction. The company has processed over 40,000 patient appointments per month, has raised approximately $33M cumulatively across seed, Series A, and an Innovate UK loan, and is now channeling a 2026 £2M Innovate UK loan into AI-powered audiology to extend the platform from hardware-enabled services into AI-assisted clinical decision support.

Name

TympaHealth

Legal name

Tympa Health Technologies Ltd

Website

https://tympahealth.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

51–100 employees

Short description

TympaHealth is a London-based health technology company that provides an integrated ear and hearing health platform combining portable HD video otoscopy, hearing checks, and microsuction wax removal, deployed across UK pharmacies, care homes, audiology clinics, and US primary care and value-based hospital systems.

Ownership category

akta.pro rank

Product category

Hearing Healthcare Software and Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Otology & Neurotology (Ear/Hearing/Balance) (HLAKAMAC)

Keywords

• Ear care platform
• Hearing healthcare software
• Video otoscopy devices
• Microsuction equipment
• Audiology clinical tools

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain

Revenue model

1. Device/Platform Subscription: Subscription-based access to the Tympa platform including hardware and software, with training and ongoing support bundled into the service
2. Consumables: Ongoing sales of specula, suction tubes, filters, and accessories required for Tympa procedures
3. Training Services: Accredited training programs through Tympa Academy for practitioners, including online education, webinars, and face-to-face coaching leading to certification

Pricing tiers

Go-to-market motion3 records

Distribution channels6 records

Marketing channels7 records

Core offering

TympaHealth sells the Tympa platform, a portable, all-in-one ear and hearing health assessment device that combines HD video otoscopy, 4-frequency hearing checks (500Hz–4kHz), and microsuction wax removal, paired with the TympaCloud digital patient record system, in-app specialist referral, and ongoing practitioner training through Tympa Academy. The device is CE marked as a Class 1 medical device and FDA registered, and is sold via subscription to pharmacies, care homes, audiology clinics, allied health professionals, and US health systems for the delivery of community-based ear and hearing care.

Product overview

TympaHealth offers a unified ear and hearing health solution built around the Tympa device — a portable, all-in-one system combining HD video otoscopy, 4-frequency hearing checks (500Hz to 4kHz), and microsuction wax removal. The platform is complemented by TympaCloud for secure digital patient records, Tympa Academy for practitioner training and certification, and clinical support services (Advice and Guidance and Remote Review) enabling frontline healthcare professionals to deliver comprehensive ear and hearing care. The solution is designed for deployment across pharmacies, care homes, audiology clinics, and primary care settings, with NHS integration demonstrated through the South West London ICB pilot program. The company is expanding AI capabilities, having received £2M Innovate UK funding for AI-powered audiology development.

Differentiator

Problem solved

Functional benefit

Products and services

• Tympa Device and Platform Portable, all-in-one device that combines HD video otoscopy (9.2x magnification), 4-frequency hearing check (500Hz–4kHz), and microsuction wax removal for community-based ear and hearing health assessment, CE marked as a Class 1 medical device and FDA registered. Sold via subscription to pharmacies, care homes, audiology clinics, allied health professionals, and US health systems.
• TympaCloud Cloud-based digital patient record system that securely stores and provides access to patient records, tracks patient progress over time, and shares results with specialists when needed, integrated with the Tympa device and Advice and Guidance workflow.
• Tympa Academy Accredited training and certification program delivered by ENT and audiology professionals, covering otoscopy, hearing checks, and aural care using microsuction via webinars, online education, face-to-face coaching, and a digital logbook. Included with platform subscription and contributes to ongoing revenue as a paid professional service.
• Advice and Guidance Clinical support service providing first-line clinical advice from ENT-trained audiologists and second-line guidance from ENT surgeon partners for complex queries, enabling frontline practitioners to deliver care without on-site specialist presence.
• Remote Review Service enabling clinicians to share otoscopy images and video with TympaHealth's clinical team (audiologists and ENT specialists) for second opinions and expert guidance on complex cases, with 95% diagnostic concordance validated against consultant otologist review in the UCLH telemedicine pilot.
• TympaHealth Hear Well Pathway NHS-integrated ear and hearing health pathway enabling community pharmacies and care settings to deliver ear examinations, wax removal, and hearing checks with specialist referral support; winner of the Nursing Times Social Care Award 2023.
• Tympa Consumables Ongoing supply of specula, suction tubes, filters, and other accessories required for Tympa procedures, sold as an ancillary revenue stream to platform subscribers.

Quantifiable outcome

• 88% reduction in specialist referrals for patients seen with the Tympa in value-based hospital settings
• +5 more outcomes

Named customers14 records

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature6 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• National Pharmacy Association (NPA)coreGTM or Marketing PartnerUK's leading trade body representing independent community pharmacies. Partnership provides marketing, training support, and access to pharmacy network.
• Care EnglandcoreGTM or Marketing PartnerLeading representative body for independent adult social care providers in England. Partnership supports marketing and access to care home network.
• Numark PharmacycoreGTM or Marketing PartnerMembership organization supporting independent community pharmacies across the UK with commercial, marketing, training, and professional services.
• Healthpoint TVminorGTM or Marketing PartnerHealthcare media platform delivering health information through digital screens in community pharmacies.
• Pharmacy MentorminorGTM or Marketing PartnerUK-based digital marketing agency helping community pharmacies with branding, web design, SEO, and advertising.
• NHS South West London ICBcoreStrategic or Co-development PartnerIntegrated Care Board that piloted the TympaHealth ear and hearing health pathway across 20 community pharmacies, generating £262,079 in net savings and proving the model for future commissioning.
• NHScoreStrategic or Co-development PartnerNational Health Service partnerships for delivering ear and hearing health services; NHS trusts and organizations using Tympa technology for patient care.
• Royal National ENT HospitalcoreStrategic or Co-development PartnerLondon hospital that collaborated on UCLH telemedicine pilot study published in BMJ Open Quality journal.
• Boots HearingcarecoreStrategic or Co-development PartnerMajor UK hearing care retailer that collaborated on remote otology care feasibility study during COVID-19 pandemic.

Scale indicators8 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• hearX Group: hearX Group offers digital hearing health screening solutions including smartphone-based audiometry and remote hearing assessment platforms. It is the most directly comparable peer, pursuing the same model of enabling non-specialist settings to deliver validated hearing assessments via connected devices.
• SHOEBOX Audiometry: SHOEBOX provides tablet-based audiometric testing and hearing screening software designed for use outside traditional audiology clinics by non-specialist staff. Like Tympa, it focuses on democratising hearing assessment through portable, validated, software-driven tools for pharmacies, primary care, and occupational health.

Broad incumbents

• Welch Allyn (Hillrom / Baxter): Welch Allyn is the incumbent leader in clinical otoscopes and otolaryngology examination instruments globally, now part of Baxter following the Hillrom acquisition. It competes with Tympa's core hardware offering but lacks the integrated cloud platform, microsuction, and AI triage features that differentiate Tympa.
• HEINE Optotechnik: HEINE is a German medical-instruments manufacturer with a flagship line of high-quality otoscopes used in GP and ENT settings worldwide. It competes on hardware quality and brand trust with Tympa's otoscope but does not currently offer integrated microsuction, cloud records, or AI-enabled triage as a single platform.
• Audika (Demant): Audika is the global retail hearing-care brand of Demant, one of the world's largest hearing-aid manufacturers, operating thousands of clinics worldwide. It overlaps with Tympa on ear-care service delivery but as part of a much broader audiology retail model rather than a deployable platform for third-party settings.

Emerging players

• CellScope: CellScope (now part of Avella) built a smartphone-attached digital otoscope for at-home and clinical use. It overlaps with Tympa on digital otoscopy but focuses more on consumer/paediatric use cases and does not offer the integrated microsuction and hearing-check workflow central to Tympa's value proposition.
• Audientes: Audientes is a Danish company developing self-fitting, over-the-counter smart hearing aids. It is adjacent rather than direct — competing more in the hearing-aid device category — but its direct-to-consumer, low-cost approach targets a similar underserved hearing-care population that Tympa serves through community channels.
• Sound Scouts: Sound Scouts is an Australian digital hearing-screening technology delivered via tablet and used in schools, occupational health, and primary care. Like Tympa, it focuses on validated hearing checks in non-specialist settings, but does not currently bundle otoscopy or wax-removal capability into its platform.

Others

• Specsavers Hearcare: Specsavers is one of the largest UK and international retail chains for optical and hearing care. It is both a potential customer for Tympa's platform (across its UK audiology footprint) and a potential competitor if it were to develop or commission its own integrated ear-care workflow in-house.

Regional players

• Amplify Hearing: Amplify Hearing is a UK pharmacy-anchored hearing-care provider offering hearing tests, wax removal, and hearing aids in community pharmacies. It is a potential channel partner for Tympa's platform in the UK and a comparable model for delivering ear-care services through pharmacy settings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@tympahealth
• Xx.com/tympahealth
• LinkedInlinkedin.com/company/tympahealth-technologies-ltd

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds4 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TympaHealth